Status:
COMPLETED
Glycyrrhetinic Acid-Effect on Serum Potassium and Insulin Resistance in Dialysis Patients
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Conditions:
End Stage Renal Disease
Eligibility:
All Genders
Phase:
PHASE2
Brief Summary
Background: 18B Glycyrrhetinic acid (active compound of Licorice) decreases serum potassium via enhanced renal potassium loss in healthy individuals and thereby inducing renal sodium retention and art...
Eligibility Criteria
Inclusion
- dialysis patients (\>3 months)
Exclusion
- diabetics
- hospital stay in the last 4 weeks
Key Trial Info
Start Date :
August 1 2006
Trial Type :
INTERVENTIONAL
End Date :
April 1 2007
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00384384
Start Date
August 1 2006
End Date
April 1 2007
Last Update
January 13 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of nephrology and hypertension, University hospital of berne
Bern, Switzerland, 3010